2|0|Public
40|$|Breast {{cancer is}} the most common cancer in woman in Poland. Metastases to the skin are rarely {{reported}} and usually they are associated with poor prognosis. The average length of survival in such patients is from 3 to 6 months. We present the patient in whom despite <b>adjuvant</b> <b>chemiotherapy</b> we observed extensive skin metastases. Despite the use of multiple courses of chemiotherapy and radiotherapy there was continous progression of skin lesions. We managed to prolong the survival of the patient. The patient survived 4 years after the first metastatic tumor in postoperative scar...|$|E
40|$|São analisados os resultados do tratamento cirúrgico em cinco casos de {{melanoma}} maligno anorretal (MMAR). Um paciente encontrava-se no estádio clínico I, dois no estádio clínico II e dois no estádio III. Todos os pacientes foram operados, sendo quatro submetidos a excisão local do tumor, e um a amputação abdômino-perineal do reto. Este último sobreviveu por apenas sete meses, enquanto uma paciente, estádio clínico II e submetida apenas à excisão local, sobreviveu por 168 meses. Os autores questionam a validade do estadiamento clínico I (tumores localizados) como fator prognóstico, já que desconsidera o grau de penetração do tumor na parede anorretal. Sugerem ainda a realização de estudos multicêntricos, para que se possa estabelecer uma uniformidade terapêutica para o MMAR. In {{spite of}} being rare, the anorectal region {{is the third}} most frequent localization of the melanoma, following the skin and eyes. The results of treatment are conflictant, with variable averange survival of 2, 7 months until 30 months in patients submitted to surgical treatment. In this study, the results of surgical treatment in five cases of malignant anorectal melanoma are presented. One patient was in clinical staging I, two in II and two in III. All {{of them have been}} operated, four submitted to local excision of the tumor and one to abdominoperineal amputation of the retum. Two patients were submitted to <b>adjuvant</b> <b>chemiotherapy</b> and one to radiotherapy and inespecific imunotherapy with oral BCG. The unique patients in the stage I had a survival of 13 months, similar to the patients III (average survival = 14 months), and inferior to the patients II (average survival = 87, 5 months). The authors question the validity of the clinical stage I (localizated tumours) like a prognostic factor, because it desconsider lhe penetration grade of the tumour in tha anorectal wall. The still suggest the realization of multicentric studies to allow the establishment of a therapeutic uniformity to the malignant anorectal melanoma...|$|E

